Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 2,081,100 | 1,847,300 | 1,841,200 | 1,947,300 | 1,217,800 |
| Cost of Goods | 1,786,200 | 1,604,800 | 1,565,700 | 1,660,000 | 1,044,000 |
| Gross Profit | 294,900 | 242,500 | 275,500 | 287,300 | 173,800 |
| Operating Expenses | 248,100 | 207,500 | 205,700 | 264,800 | 204,100 |
| Operating Income | 47,000 | 35,800 | 70,500 | 22,500 | -30,300 |
| Interest Expense | 8,800 | 3,600 | 9,400 | 14,200 | 7,200 |
| Pre-tax Income | 38,200 | 32,200 | 61,100 | 8,300 | -37,500 |
| Income Tax | 14,800 | 13,000 | 18,900 | 3,300 | -13,400 |
| Net Income Continuous | 23,400 | 19,200 | 42,200 | 5,000 | -24,100 |
| Net Income | $23,400 | $19,200 | $42,200 | $5,000 | $-24,100 |
| EPS Basic Total Ops | 0.80 | 0.64 | 1.39 | 0.17 | -1.13 |
| EPS Basic Continuous Ops | 0.80 | 0.64 | 1.39 | 0.17 | -1.13 |
| EPS Diluted Total Ops | 0.79 | 0.64 | 1.39 | 0.17 | -1.13 |
| EPS Diluted Continuous Ops | 0.79 | 0.64 | 1.39 | 0.17 | -1.13 |
| EPS Diluted Before Non-Recurring Items | 1.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $78,900 | $64,500 | $97,900 | $51,400 | $-9,900 |